HealthNew drug daraxonrasib shrinks pancreatic tumours in early trial
Taken daily with chemotherapy, daraxonrasib stopped tumour growth in about 90 per cent of 61 patients with spread pancreatic cancer in an early trial; doctors stress it is not a cure.
